Beijing Kawin Technology Share-holding Co Ltd - Asset Resilience Ratio
Beijing Kawin Technology Share-holding Co Ltd (688687) has an Asset Resilience Ratio of 12.53% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Kawin Technology Share-holding C (688687) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Beijing Kawin Technology Share-holding Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 688687 total assets.
Liquid Assets Composition Over Time
This chart breaks down Beijing Kawin Technology Share-holding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Beijing Kawin Technology Share-holding C (688687) financial obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥337.92 Million | 12.53% |
| Total Liquid Assets | CN¥337.92 Million | 12.53% |
Asset Resilience Insights
- Moderate Liquidity: Beijing Kawin Technology Share-holding Co Ltd has 12.53% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Beijing Kawin Technology Share-holding Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Kawin Technology Share-holding Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX |
Biotechnology | 15.95% |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Halozyme Therapeutics Inc
NASDAQ:HALO |
Biotechnology | 12.71% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
Biotechnology | 33.23% |
|
Nanobiotix
NASDAQ:NBTX |
Biotechnology | 4.71% |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
Biotechnology | 65.12% |
Annual Asset Resilience Ratio for Beijing Kawin Technology Share-holding Co Ltd (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Beijing Kawin Technology Share-holding Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.29% | CN¥287.50 Million ≈ $42.07 Million |
CN¥2.79 Billion ≈ $408.72 Million |
-3.12pp |
| 2024-12-31 | 13.41% | CN¥350.87 Million ≈ $51.34 Million |
CN¥2.62 Billion ≈ $382.75 Million |
-1.51pp |
| 2023-12-31 | 14.92% | CN¥365.33 Million ≈ $53.46 Million |
CN¥2.45 Billion ≈ $358.25 Million |
-8.21pp |
| 2022-12-31 | 23.13% | CN¥511.12 Million ≈ $74.79 Million |
CN¥2.21 Billion ≈ $323.35 Million |
+19.46pp |
| 2021-12-31 | 3.67% | CN¥80.00 Million ≈ $11.71 Million |
CN¥2.18 Billion ≈ $318.67 Million |
-- |
About Beijing Kawin Technology Share-holding Co Ltd
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhiz… Read more